Novartis and Janssen won the 2014 UK’s Prix Galien awards. Novartis won the Innovative product award for their breakthrough meningitis b vaccine and Janssen won the Orphan drug award for their tuberculosis medicine bedaquiline, which is the first new treatment for this disease in four decades.